Ellie® Orlistat Capsules advocate a healthy weight loss concept, reducing oil absorption from the source and controlling energy intake.

Zhien Bio was established in April 2001. The company has R&D bases, raw materials and preparation production bases and sales companies in various places. It is a national high-tech enterprise integrating pharmaceutical R&D, manufacturing, sales and health services. The company focuses on building a full life cycle management service system for drugs. Through the "product (service) delivery + commodity trading service", it uses MAH (pharmaceutical marketing authorization holder) as the core, providing R&D, manufacturing, transaction promotion, and post-marketing. Research and other drugs throughout the life cycle.

The company insists on using innovative development as the driving force and builds core R&D capabilities. The R&D team has more than 20 core experts with more than ten years of R&D management experience in pharmaceutical companies at home and abroad, and more than 80% of them are undergraduate or above. The products under research cover different fields such as chemical drugs, biological drugs and traditional Chinese medicine. There are more than 50 projects under research, with key technologies for asymmetric catalytic synthesis, synthetic biology (enzyme catalytic technology), slow-release preparation technology, and liposome preparations. technology and other core technologies. Accumulated 46 production approvals, 117 domestic and foreign patents, and 666 authorized trademarks have been obtained. Obtained national qualifications such as the National Enterprise Technology Center, the National Specialized and New "Little Giant" Enterprise, the National Intellectual Property Demonstration Enterprise, the National and Local Joint Engineering Research Center for Advanced Drug Manufacturing Technology; obtained the Chongqing Postdoctoral Research Station and Chongqing New Drug Design Project Technology Research Center, Chongqing Chiral Drug Engineering Technology Research Center, Innovation Drug and Advanced Drug Manufacturing Technology Engineering Research Center and many other municipal honors.

The company's key products have been listed include Orlistat capsules (weight loss drugs), donepezil hydrochloride tablets (Alzheimer's drug), ropinirole hydrochloride tablets (Parkinson's disease drug), and quetiapine fumarate sustained release Tablets (antipsychotic drugs), totansetron hydrochloride injection (chemotherapy, radiotherapy drugs). Among them, the company's flagship product Orlistat uses the world's first asymmetric catalytic full synthesis technology, and its core patented technology won the second prize of the National Technical Invention. The company is currently the world's largest supplier of orlistat raw materials and preparations, and has a production base that has achieved full synthesis of raw materials and has achieved domestic production earlier in China. Focusing on the pharmaceutical industry service chain, the company has invested in the construction of multiple research and development and manufacturing bases such as chemical raw materials, chemical preparations, biological drugs, traditional Chinese medicine, and vaccines, and has advanced transformation and manufacturing capabilities in chemical drugs, traditional Chinese medicine, and biological drugs.